- Home
- PULM vs MGRX Comparison
PULM vs MGRX Comparison
Compare PULM & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PULM | MGRX |
|---|---|---|
| Founded | 2003 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4M | 7.1M |
| IPO Year | 2013 | 2023 |
Fundamental Metrics
Financial Performance| Metric | PULM | MGRX |
|---|---|---|
| Price | $1.26 | $0.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 32.5K | ★ 565.1K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 46.18 | ★ 55.17 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $7,910,000.00 | $456,021.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5069.93 | N/A |
| 52 Week Low | $1.16 | $0.27 |
| 52 Week High | $9.37 | $2.75 |
Technical Indicators
Market Signals| Indicator | PULM | MGRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.47 | 44.98 |
| Support Level | $1.18 | $0.32 |
| Resistance Level | $1.46 | $0.49 |
| Average True Range (ATR) | 0.10 | 0.05 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 33.33 | 13.44 |
Price Performance
Historical ComparisonAbout PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.